Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissue
Richard D Bell1,2, Matthew Brendel3, Maxwell A Konnaris4,5
1Arthritis and Tissue Degeneration Program and Research Institute, Hospital for Special Surgery, New York, NY, USA. bellr@hss.edu.
We developed an automated computational pathotyping pipeline to analyze synovial tissue in rheumatoid arthritis (RA). This cost-effective tool aids in identifying distinct RA phenotypes for targeted therapies in preclinical and clinical research.
Area of Science:
- Immunology
- Computational Pathology
- Rheumatology
Background:
- Rheumatoid arthritis (RA) is a complex immune-mediated inflammatory disease characterized by inflammatory-erosive arthritis.
- Synovial tissue heterogeneity in RA reveals distinct cellular phenotypes (pauci-immune, diffuse, lymphoid), indicating varied etiologies.
- The need for cost-effective phenotyping tools is crucial for developing targeted therapies in RA research.
Purpose of the Study:
- To develop and validate an automated multi-scale computational pathotyping (AMSCP) pipeline for analyzing human and mouse synovial tissue.
- To enable cost-effective phenotyping of RA for preclinical and clinical applications.
- To demonstrate the pipeline's efficacy, efficiency, and robustness in discovering novel RA phenotypes.
Main Methods:
- Development of an automated multi-scale computational pathotyping (AMSCP) pipeline.
- The pipeline includes two components: tissue type segmentation and cell type classification within tissue compartments.
- Application of the pipeline to both human and mouse synovial tissue samples.
Main Results:
- Demonstrated the efficacy, efficiency, and robustness of the AMSCP pipeline.
- Successfully characterized tissue-level changes and assessed cellular changes across disease states.
- Showcased the pipeline's capability to discover novel RA phenotypes.
Conclusions:
- The AMSCP pipeline provides a valuable, cost-effective method for RA research.
- Facilitates detailed analysis of synovial tissue heterogeneity.
- Supports the development of targeted therapies by enabling precise phenotyping in both preclinical and clinical settings.
More Related Videos
12:44Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
Published on: January 27, 2023
11:03A Cryo-pulverization Protocol for Processing Mouse Paws to Evaluate Molecular Pathways of Tissue Inflammation in a Collagen Induced Arthritis Model
Published on: October 30, 2019
